abstract |
The present invention provides bicyclic azaheterocyclobenzylamines of Formula I: n n n n n n n n n n wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases. |